Ruan v. United States

This case consolidates the appeals of two physicians, Xiulu Ruan and Shakeel Kahn, who were convicted under the Controlled Substances Act for unlawfully distributing opioids. They challenged the jury instructions, which allowed conviction based solely on an objective finding that their prescriptions fell outside the usual course of professional practice, without requiring proof that they subjectively knew their actions were unauthorized. The Supreme Court examined whether 21 U.S.C. § 841 requires the government to prove mens rea regarding the prescription's invalidity. The ruling centered on the statutory phrase "except as authorized" and whether it operates as a substantive element requiring a guilty mind, or merely as a statutory defense. The Court held that once a defendant produces evidence of authorization, the government must prove beyond a reasonable doubt that the defendant knowingly or intentionally acted in an unauthorized manner.

The Supreme Court unanimously vacated the lower court judgments and remanded the cases. In the majority opinion by Justice Breyer, the Court held that the "except as authorized" clause is not a mere affirmative defense, but a substantive element of the offense. The government must prove beyond a reasonable doubt that the defendant knowingly or intentionally acted in an unauthorized manner, rejecting the objective standard used in many circuits.

Whether the government must prove that a physician subjectively knew a prescription was not for a legitimate medical purpose in the usual course of professional practice, or whether an objective standard of unreasonableness is sufficient to convict under the Controlled Substances Act.

The decision significantly raises the bar for prosecuting physicians in prescription opioid cases, requiring proof of criminal intent rather than mere medical misjudgment. It provides critical legal protection for doctors acting in good faith and alleviates fears of hindsight-based prosecutions, while still allowing pursuit of true pill mills. The ruling has reshaped the intersection of healthcare regulation, criminal law, and national opioid crisis policy.